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Abstract
Background: To assess the internal construct validity of the Perceived Impact of Problem Profile
(PIPP), a patient based outcome measure based on the International Classification of Functioning,
Disability and Health (ICF), which assesses impact and distress, in an osteoarthritis (OA) cohort.
Methods: A questionnaire comprising the 23-item PIPP, which assesses five domains (mobility,
participation, self care, psychological well being and relationships), the Western Ontario
McMasters University Osteoarthritis Index (WOMAC), the General Well-Being Index (GWBI),
and the Hospital Anxiety and Depression Scale (HADS) was posted to people with clinician
diagnosed OA. Assessment of the internal construct validity of the PIPP was undertaken using
Rasch analysis performed with RUMM2020 software and concurrent validity through comparator
measures.
Results: Two hundred and fifty-nine participants with OA responded. Analysis of the five individual
domains of the PIPP indicated that there was good fit to the Rasch model, with high person
separation reliability. One item required removal from the Mobility subscale and the Participation
subscale. There were strong correlations between the PIPP Mobility scores and the WOMAC
disability and pain subscales (rho = .73 and rho = .68), and between the PIPP Psychological well-
being and HADS Depression (rho = .71) and GWBI (rho = -.69). High inter-correlations between
the impact and distress subscales for each domain (range rho = .85 to .96), suggested redundancy
of the latter.
Conclusion: This study demonstrates that the PIPP has good psychometric properties in an OA
population. The PIPP, using just the impact subscales, provides a brief, reliable and valid means of
assessing the impact of OA from the individual's perspective and operationalizing the bio-
psychosocial model by the application of a single multi-domain questionnaire.
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Background
Osteoarthritis (OA) is the most common cause of muscu-
loskeletal pain [1] and is one of the ten most disabling dis-
eases in developed countries [2]. Worldwide estimates
indicate that one in ten men and one in five women aged
over 60 have symptomatic OA [2]. Those with arthritis
report significant pain and functional limitations [3,4],
and are more likely to perceive themselves as mentally
and physically unhealthy [5] and they represent a consid-
erable burden on health care expenditure [6-8]. While OA
of the hip and knee account for the largest component of
the burden of the disease [9,10], the wider impact and dis-
tress of living with OA has generally been poorly
described in the literature. While several outcome-based
tools have been developed to evaluate OA, such as the
WOMAC [11] and the Lequesne Index [12] they predom-
inately measure pain and function, which has been the
focus of the majority of OA research to date. However,
increasing emphasis is being placed upon the socioeco-
nomic and psychosocial issues associated with OA [13],
attempting to measure the constructs patients consider to
be important [14-16] and widen the understanding of the
consequences of disease to the broader bio-psychosocial
model [17].
One recently developed instrument attempts to capture
some of the key elements of such a model, incorporating
elements of the International Classification of Functioning,
Disability and Health (ICF) [17], as well as key psycholog-
ical components such as well-being. The Perceived Impact
of Problem Profile (PIPP) [18] was developed to provide a
generic research and clinical measurement tool to assess
both the impact and distress of health conditions from the
individuals' perspective. It contains a set of standardized
domains (Self-care, Mobility, Participation, Relationships,
and Psychological Well-being) to allow comparison of
scores across patient groups and within individuals over
multiple time points. The selection of domains was guided
in part by the ICF, together with a review of existing meas-
ures, and a series of qualitative interviews. Consequently,
items were selected to assess the impact and distress of the
health condition on Activities and Participation (ICF Chap-
ters 4 to 9) [19], and on the individual's psychological well-
being (including independence and autonomy), an area
not yet well addressed in the ICF.
The psychometric properties of the PIPP were previously
assessed using Rasch analysis in a sample of those with
locomotor disorders [18]. All subscales recorded adequate
person separation reliability and no evidence of item bias
for sex, age, educational achievement or rural versus
urban residence. Preliminary validity testing using the
individual items from the EQ5D provided support for the
PIPP subscales [18]. Further validation across a range of
health conditions and patient groups was recommended.
The aim of the current study was to extend the validity
testing of the PIP by (a) assessing the psychometric prop-
erties of the PIPP in a sample of patients with OA and (b)
exploring the impact of OA on patients' lives across each
of the ICF domains represented on the PIPP.
Methods
Participants
A postal survey was sent to 635 people in Leeds (UK) with
OA. Participants were included if they were attending
either the primary (Leeds Musculoskeletal Service) or sec-
ondary care (Rheumatology or Orthopaedics Clinics)
services and had a positive diagnosis of OA. Participants
with hip, hand and knee OA were included if they fulfilled
the ARC Criteria for the Diagnosis of OA [20-22]; in the
absence of any such criteria for foot OA, patients were
included if they had symptomatic pain that was con-
firmed by clinician diagnosis of OA. Non-responders were
sent two reminder letters, after which they were deemed to
not wish to be part of the study.
Materials
Participants were sent a questionnaire pack which
included demographic information, (e.g. age, gender), co-
morbidities (self reported, as diagnosed by a doctor or
health professional and reported by the participant), the
site(s) of OA, and the following validated measures:
• The Perceived Impact of Problem Profile (PIPP) [18]
consists of 23 items, measuring five domains (Mobil-
ity, Self-care, Relationships, Participation and Psycho-
logical Well-being). It was developed as a generic
research and clinical tool to assess the impact and dis-
tress associated with a health condition. For each item,
respondents were asked to rate (a) 'how much impact
has your current health problems had on [item of
function or activity]'; and (b) 'How much distress has
been caused by the impact of your health problem on
[same item of function or activity]'. The 6-point scale
was anchored by 'no impact' and 'extreme impact' for
the Impact scales and by 'no distress' and 'extreme dis-
tress' for the Distress scales.
￿ The Western Ontario McMasters University Osteoar-
thritis Index (WOMAC) is a disease specific question-
naire where statements are rated on a 0 (no problem)
to 4 (extreme problem) over three domains, including
pain, stiffness and physical function [23]. It is widely
used in the OA literature, has been shown to be more
responsive than other measures of knee pain [24,25],
demonstrates good construct validity, particularly for
the pain and physical function domains [23,24] and
has been found to be a stable and reliable postal sur-
vey tool [26]. While designed primarily for hip and
knee OA, the WOMAC has been used previously inHealth and Quality of Life Outcomes 2009, 7:37 http://www.hqlo.com/content/7/1/37
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validation purposes of other instruments associated
with the lower limb[27,28].
￿ The General Well Being Index (GWBI) is a measure
that has been specifically designed to assess psycho-
logical distress rather than physical incapacitation
[29]. Statements are rated on a scale from 1 (signifi-
cant distress) to 4 (no distress). It has been used in
numerous clinical and non patient based groups [30].
It has demonstrated good internal consistency [31]
and high test re-test reliability [30] and has been spe-
cifically adapted and validated for use in England [32].
￿ The Hospital Anxiety and Depression Scale (HADS)
[33] is a 14-item scale designed to detect anxiety and
depression, independent of somatic symptoms. It con-
sists of two 7-item subscales measuring depression
and anxiety. A 4-point response scale (from 0, repre-
senting absence of symptoms, to 3, representing max-
imum symptomatology) is used, with possible scores
for each subscale ranging from 0 to 21. Higher scores
indicate higher levels of disorder.
The research was conducted in compliance with the Hel-
sinki Declaration with institutional review and ethical
approval granted by the Leeds West Ethics Review Board.
Statistical analyses
Rasch analysis is an iterative procedure which assesses a
number of measurement attributes, as well as the assump-
tions which underpin the model [34,35]. The Rasch
model shows what should be expected in responses to
items if measurement (at the metric level) is to be
achieved [36]. The model can be extended to the polyto-
mous case and the version used here is that developed by
Masters [37]. As the model specifies what is needed to
transform ordinal into interval level data, the heart of the
procedure is the assessment of fit of data to the model's
expectations. A variety of fit statistics determine if this is
the case [38]. Generally non-significant deviations from
the model expectations are expected for chi-square-based
statistics, and within range (± 2.5) for residual fit statistics.
Two summary fit statistics for items and persons have an
expected mean of zero, and standard deviation of one
when data have perfect fit to the model [34].
Other aspects of Rasch analysis are concerned with testing
model assumptions (such as local dependency and unidi-
mensionality) and with the investigation of other
attributes such as appropriate category response structure
(for polytomous items) and for item bias, or differential
item functioning (DIF) [39]. Full details of these proce-
dures are given elsewhere [34,35]. The software used was
RUMM2020 for the Rasch analysis [40], and SPSS Version
12.0 for other analyses.
For the Rasch analysis, a sample size of 150 patients is suf-
ficient to estimate item difficulty to within ± 0.5 logits,
with α of 0.01, and β of 0.2 [41]. This sample size is also
sufficient, with the same power, to test for DIF where a dif-
ference of 0.5 standard deviations within the residuals can
be detected for any two groups. It is important to note that
Rasch analysis is distribution free, and does not require a
'representative' sample, but rather needs a good spread of
respondents across the construct to be measured.
Results
Descriptive statistics
Of 635 questionnaires sent out, 390 were returned, a
response rate of 61.4%. Of those returned, 65% com-
pleted the questionnaire, while 35% replied that they
would not like to participate. This gave 259 valid respond-
ents, well above the minimum sample size requirements.
Initial analysis was undertaken in order to explore the
potential of any responder bias and found that there were
no differences in age or gender between responders and
non-responders. The majority of the respondents were
females (68.7%), with a mean age of 66.49 years (range:
21 to 98, SD 12.5 yrs) and mean disease duration of 12.6
years (range: 6 months to 45 years; SD 9.1 yrs). Almost
one quarter of the sample was in paid employment. While
the knee was the most common site of pain (40.2%), this
was followed closely by the hand (39.8%), the foot
(28.6%) and hip (23.9%). Multiple joint involvement
was common, with the median number of joints affected
being four. Only 11% of respondents reported only one
site.
Rasch analysis
Rasch analysis was conducted for each of the individual
subscales of the PIPP with separate analyses reported for
the PIPP Impact and PIPP Distress subscales. In the previ-
ous validation of the PIPP [18] a global recoding was con-
ducted across all items to resolve disordered thresholds.
This resulted in adequate PSI values (above .7) but these
values were less than optimal for use at the individual
level (requiring values above .85). In the current study,
disordered thresholds were not rescored where overall
model fit was achieved [42]. If misfit was observed, then
individual rescoring was attempted and retained if fit
improved. Marginally disordered thresholds were left
unchanged.
The overall fit statistics for each subscale are presented in
Table 1. Both the Impact and Distress Self-care scales
showed good model fit and excellent person separation,
with no misfitting items or DIF for sex, age or duration of
disease. The overall fit statistics for the Impact Mobility sub-
scale initially suggested some misfit to the Rasch model,
however removal of item 11 (ability to use a vehicle) resulted
in good fit to the model, with strong person separation reli-Health and Quality of Life Outcomes 2009, 7:37 http://www.hqlo.com/content/7/1/37
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ability. No DIF was detected for gender or age. In the PIPP
Distress Mobility subscale, item 12 (ability to move around
and within your house) was removed resulting in adequate fit
to the model (after Bonferonni adjustment), good person
separation, and no further misfitting items and DIF.
It was necessary to remove item 14 (your ability to partici-
pate in family activities) from the Impact Participation sub-
scale in order to achieve satisfactory fit. No DIF was
detected for gender, but two items in the Impact Participa-
tion subscale (item 15, 16) recorded DIF for age with item
16 showing higher probabilities for the under 67 years
group and item 15 showing higher probabilities for the
older age group (68 + years). The two items appear to be
acting in opposite directions with respect to age, suggest-
ing no bias at the subscale level. This was confirmed by
comparing the person estimates derived from all items,
with those derived from only DIF free items. The estimates
at the individual person level were found to differ by less
than 0.3 of a logit. It was therefore decided to retain both
items in the Impact Participation subscale. The Distress
Participation subscale recorded no evidence of DIF and
showed overall model fit, with good person separation
reliability, and no misfitting items.
The two Relationships subscales achieved good overall
model fit, with high person separation reliability and no
misfitting items. The targeting map for both subscales
showed a skewed distribution with a floor effect indicating
that a substantial proportion of the sample experienced
very little impact of their health problem on relationships.
The PIPP Impact Psychological Wellbeing scale initially
showed good fit to the model; however two items (item 2:
Your moods and feelings, item 23: Your reliance on others for
help) showed DIF for age with item 2 showing higher prob-
abilities for the under 67 yrs group and item 23 showing
higher probabilities for the older age group (68 + years).
Again no significant differences were found in the magni-
tude of person estimates derived from all items, compared
to those without DIF. One item in the Distress Psychologi-
cal Wellbeing subscale (item 23) also showed significant
DIF for age, but comparison of person estimates showed lit-
tle difference, therefore all items were retained.
After achieving fit to the Rasch model for all PIPP scales
further testing was conducted to ensure unidimensional-
ity. Independent t-tests compared person estimates
derived from subsets of items identified from Principal
Components Analysis of the residuals. All PIPP scales met
the criteria for unidimensionality, with no more than 5%
of t-values exceeding ± 1.96.
Validation of PIPP subscales
The linear Rasch derived person estimates for each sub-
scale were exported from RUMM2020 to SPSS. Among the
Impact subscales (shown in the lower section of Table 2)
the strongest correlation was between the Mobility and
Participation scales (rho = .86) while the lowest was
between the Self care and Relationship scales (rho = .53).
A similar pattern of correlations were also observed
among the Distress scales (see upper section of Table 2)
with values ranging from .57 (Self Care and Relation-
ships) to .90 (Mobility and Participation). This suggests
that health problems that impact on an individual's
mobility are also likely to have a substantial impact on
their ability to work and to participate in family and com-
munity activities.
The correlations between the corresponding Impact and
Distress scales are shown on the diagonal in Table 2. The
Table 1: Final fit statistics for each PIPP subscale
Analysis No. items Item Fit
Residual
Person Fit Residual Chi-Square Interaction Person Separation PSI
Mean SD Mean SD Chi-square (df) p
Impact
Self care 4 0.052 1.108 -0.398 1.103 9.305 (8) 0.317 0.932
Mobility 4 0.147 1.67 -0.378 .935 13.82(8) 0.086 0.92
Participation 4 0.285 0.510 -0.437 1.065 11.495 (8) 0.175 0.899
Relationships 4 0.004 1.156 -0.479 1.221 14.769(8) 0.064 0.955
Psychological 5 -0.164 0.388 -0.491 1.186 11.474(10) 0.32 0.900
Distress
Self care 4 -0.205 1.15 -0.498 1.033 12.13(8) 0.145 0.92
Mobility 4 0.182 0.634 -0.366 0.982 13.381(8) 0.099 0.884
Participation 5 0.252 1.402 -0.507 1.255 20.755(10) 0.023 0.936
Relationships 4 0.037 1.059 -0.399 1.051 11.163(8) 0.193 0.956
Psychological 5 -0.106 0.320 -0.538 1.195 6.731(10) 0.751 0.918
Ideal Value 0.000 1.000 0.000 1.000 >0.05 >0.7Health and Quality of Life Outcomes 2009, 7:37 http://www.hqlo.com/content/7/1/37
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strongest correlation was between the Relationship
impact and distress subscales (rho = .96) with only
slightly lower values for the other scales. These uniformly
strong inter-correlations suggest a strong overlap between
the ratings of the impact of a health problem and the dis-
tress that this causes. With up to 92% shared variance this
is indicative of redundancy, suggesting the removal of one
of the sets of scales. This was explored further by assessing
the predictive ability of the PIPP scales against other vali-
dated measures.
Correlations with other measures
Consistent with expectations, there were strong correla-
tions between the PIPP and WOMAC (see Table 3). The
pain and physical function subscales of the WOMAC cor-
related strongly with the Mobility and Participation sub-
scales of the PIPP. These results suggest that respondents
with high levels of pain and disability as measured by the
WOMAC, report substantial impact and distress on the
various aspects assessed by the PIPP scales. In particular,
pain and disability had the greatest impact on respond-
ents' levels of mobility and their ability to participate in
family and social activities.
Inspection of the correlation matrix (see Table 3) also
showed strong correlations between the two PIPP Psycho-
logical Wellbeing scales (impact and distress) and HADS
Depression (rho = .71, rho = .68), the HADS Anxiety scale
(rho = .60, rho = .65), and the General Wellbeing Index
(rho = -.69, rho = -.73). Respondents reporting high
impact and distress caused by their osteoarthritis also
recorded higher levels of anxiety and depression, and
lower levels of general wellbeing.
The equivalent strength of the observed relationships for
the PIPP Impact and the Distress scales support the earlier
suggestion of redundancy. Each of the pairs of correla-
tions were of similar strength with the WOMAC, HADS
and General Wellbeing Index. The Distress subscales
appear to offer no further explanatory value over that pro-
vided by the Impact subscales.
Number of pain sites
In order to test the capacity of the PIPP to discriminate
between two groups of patients who would be expected to
demonstrate differences in their PIPP responses, the
impact and distress of OA at several sites was explored.
Table 2: Spearman correlations among Rasch derived PIPP subscale scores
Self care Mobility Relationships Participation Psychological
Self care .93 .69 .57 .69 .70
Mobility .65 .85 .59 .90 .87
Relationships .53 .60 .96 .60 .66
Participation .60 .86 .57 .88 .87
Psychological .66 .85 .67 .85 .92
Correlations among distress subscales are shown in italics in the top right diagonal of the table.
Correlations among impact subscales are shown in the bottom left diagonal of the table.
Correlations between corresponding impact and distress subscales are shown in bold on the diagonal.
Pairwise deletion of missing data: Ns ranged from 153 to 219.
All correlations significant at p < .001.
Table 3: Spearman correlations between Rasch derived PIPP subscale scores, WOMAC, HADS and General Wellbeing
WOMAC Pain WOMAC Disability HADS Depression HADS Anxiety General Wellbeing
Impact
Self-care .49 .59 .48 .45 -.55
Mobility .68 .73 .63 .50 -.61
Relationship .36 .49 .55 .44 -.52
Participation .66 .71 .59 .43 -.52
Psychological .65 .70 .71 .60 -.69
Distress
Self-care .52 .58 .50 .42 -.54
Mobility .62 .68 .60 .55 -.62
Relationship .39 .50 .50 .44 -.54
Participation .69 .73 .62 .53 -.59
Psychological .64 .67 .68 .65 -.73
Pairwise deletion of missing data: Ns ranged from 131 to 195.
All correlations significant at p < .001.Health and Quality of Life Outcomes 2009, 7:37 http://www.hqlo.com/content/7/1/37
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The number of pain sites recorded for each participant
ranged from 1 to 14 (mean = 4.7, SD = 3.0, median = 4).
A median split was utilized to create two groups (1 to 4
sites versus 5 to 14 sites). Mann-Whitney U tests compar-
ing PIPP subscale scores for the two groups (see Table 4)
showed statistically significant differences on all PIPP
scales. In support of the validity of the PIPP, individuals
with multiple pain sites reported higher levels of impact
and distress across the aspects assessed by the PIPP.
Discussion
The aim of this study was to assess the psychometric prop-
erties of the PIPP scales using Rasch analysis and to inves-
tigate the impact and distress of OA from the patients'
perspective. The PIPP subscales showed good fit to the
Rasch model after minor adjustments to some scales. In
the PIPP Impact Mobility subscale, item 11 (ability to use a
vehicle) was identified for removal based on both empiri-
cal and qualitative grounds. Feedback from respondents
suggested some confusion as to whether the item refers to
the ability to use a vehicle as driver or passenger. After
removal of this item all subscales showed high levels of
person separation reliability, at levels (above .9) suitable
for assessment at both the group and individual levels.
Validity testing provided support for the use of the PIPP in
this OA sample. The scales showed strong and appropriate
correlations with the WOMAC – participants with high levels
of pain and disability as measured by the WOMAC reported
high levels of impact and distress on the PIPP. Both PIPP Psy-
chological Wellbeing scales correlated strongly with the
HADS and the General Wellbeing Index. The strength of
these relationships suggest that the PIPP could be used as a
short assessment tool for several key constructs, reducing the
need for substantial batteries of questionnaires when this
may be contextually inappropriate or too time consuming.
The PIPP was originally designed to assess two related but
distinct aspects of a health condition – impact and distress
[18]. The results of the current study indicate that there is
a very strong correlation between the two sets of scales
and that they correlate in a very consistent manner with
other validated measures. The distress subscales fail to add
anything to the predictive power of the impact scales, sug-
gesting that respondents were judging impact in relation
to the amount of distress experienced. Therefore in future
studies it is recommended that only the Impact subscales
be administered, shortening the scale and reducing the
load on respondents.
The study had a number of weaknesses. While the number
of respondents returning questionnaires exceeded the
minimum sample size requirements, the skewed scores of
some subscales indicated the lack of uniformity of sample
distribution which would have given the greatest degree
of precision for item and person estimates. This was par-
ticularly so for the Relationships subscale and further
work is needed to strengthen the evidence to support the
validity of this scale. Again while the sample was large
enough for this initial validation in OA, a much higher
response rate, including higher agreement to participate
amongst those returning a questionnaire, would have
given the opportunity to have a 'set aside' sample to inde-
pendently validate the revised subscales.
In the current study the external construct validation of
the PIPP was tested against the pain and function sub-
scales of the WOMAC. Although widely used in both
research and clinical contexts, some studies using Rasch
analysis have raised some concerns about the dimension-
ality, item fit and psychometric properties of the WOMAC
[43,44]. Further research is needed using other well vali-
dated measures to confirm these findings.
Table 4: Comparison of Rasch derived PIPP subscale scores for low versus high numbers of pain sites
1 to 4 sites 5 to 14 sites
N Median N Median Mann-Whitney U Z p
Impact
Self-care 93 -3.39 93 -2.67 3442 -2.50 .012
Mobility 103 -1.36 98 -.25 3544 -3.65 .000
Relationship 93 -3.39 92 -2.28 3481 -2.30 .022
Participation 101 -.69 97 -.037 3318 -3.92 .000
Psychological 104 -1.04 98 -.25 3518 -3.80 .000
Distress
Self-care 71 -3.13 84 -2.00 2436 -2.06 .039
Mobility 83 -1.00 89 -.30 2617 -3.30 .001
Relationship 71 -3.39 81 -2.51 2227 -2.51 .012
Participation 86 -1.12 86 -.22 2797 -2.76 .006
Psychological 87 -1.18 85 -.26 2444 -3.84 .000
Median values are Rasch derived person estimates ranging from -4.2 to +9.1 with high positive scores indicating higher impact or distress.Health and Quality of Life Outcomes 2009, 7:37 http://www.hqlo.com/content/7/1/37
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The study also has a number of strengths. The sample rep-
resented a wide range of joint involvement making the
work generalisable for OA. The Rasch measurement
model is state-of-the-art in measurement science, placing
the most rigorous demands upon data quality, satisfying
the basic axioms for constructing interval scale measure-
ment [45].
Conclusion
In conclusion, measuring the impact of OA from the per-
spective of the bio-psychosocial model provides impor-
tant information on the wider patient-perceived impact of
the disease, rather than focussing on impairment and
activity limitation. As such, the PIPP provides a different
perspective to existing outcome measures used in OA, and
offers a multi-domain capability for examining the com-
plex inter-relationships that exist within the bio-psycho-
social model. Given this sample included several different
locations of OA and multiple joint presentation, the
shortened version, using only the impact scales of PIPP,
demonstrated good internal construct validity for use in a
wide range of OA presentations.
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